Moxifloxacin Prophylaxis against MDR TB, New York, New York, USA
Contacts of persons infected with multidrug-resistant tuberculosis (MDR TB) have few prophylaxis options. Of 50 contacts of HIV- and MDR TB–positive persons who were treated with moxifloxacin, 30 completed treatment and 3 discontinued treatment because of gastrointestinal symptoms. Moxifloxacin was...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Centers for Disease Control and Prevention
2015
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344279/ |
| Summary: | Contacts of persons infected with multidrug-resistant tuberculosis (MDR TB) have few prophylaxis options. Of 50 contacts of HIV- and MDR TB–positive persons who were treated with moxifloxacin, 30 completed treatment and 3 discontinued treatment because of gastrointestinal symptoms. Moxifloxacin was generally well-tolerated; further research of its efficacy against MDR TB is needed. |
|---|